Back to today’s briefing

Story perspectives

China's Two Sessions: Little Change Expected in Healthcare

3/4/2026

30 5 Full Breakdown

Summary

Story summary

China's annual two sessions are set to begin this week, drawing investor attention.
Analysts expect limited near-term policy changes on drug pricing and the drug payment system since January's insurance model.
Tony Ren of Macquarie Capital says the meetings are unlikely to produce significant healthcare news.
Zhang Jialin of Nomura notes some adjustments may occur but will not immediately affect listed companies' finances.

1 of 1

Story summary

China's annual two sessions are set to begin this week, drawing investor attention.
Analysts expect limited near-term policy changes on drug pricing and the drug payment system since January's insurance model.
Tony Ren of Macquarie Capital says the meetings are unlikely to produce significant healthcare news.
Zhang Jialin of Nomura notes some adjustments may occur but will not immediately affect listed companies' finances.